Paid Clinical Trials in Bay City, MI
As of July 2026, 30 paid clinical trials are recruiting in Bay City, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Bay City offers studies at sites including McLaren Cancer Institute-Bay City for conditions such as Atopic Dermatitis, Chronic Pain, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Bay City
Trials by drug in Bay City
Filter results
Newly added in Bay City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
27 clinical trials
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Product Surveillance Registry
Top Research Study Locations in Bay City
Researchers run research studies in Bay City, MI at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| McLaren Cancer Institute-Bay City | Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Malignant Neoplasm in the Brain | 11 |
| Great Lakes Research Group, Inc. | Chronic Pain, Osteoarthritis, Knee, Atopic Dermatitis | 6 |
| Karmanos Cancer Institute at McLaren Bay Region | Advanced Solid Tumor, Hepatocellular Carcinoma Recurrent, Metastatic Colorectal Adenocarcinoma | 3 |
| Bay City | Endometriosis, Uterine Fibroids | 1 |
| Corazon Imaging | Atherosclerosis, Cardiovascular Inflammation, Coronary Artery Disease | 1 |
| Enveda Investigative Site | Atopic Dermatitis (AD) | 1 |
| Great Lakes Bay Health Centers | Cervical Dysplasia | 1 |
| Great Lakes Research Group - Bay City | Atopic Dermatitis | 1 |
| McLaren Bay Region Medical Center | Heart Failure | 1 |
| McLaren Healthcare | Deep Venous Thrombosis, Post-Thrombotic Syndrome, Venous Thromboembolism | 1 |
| McLaren Heatlh Care Corporation | AAA - Abdominal Aortic Aneurysm | 1 |
Active & Upcoming Studies in Bay City (2026)
Recruiting trials in Bay City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (13 active studies)
- TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma · Barbara Ann Karmanos Cancer Institute
- Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies · Phase 1 · Barbara Ann Karmanos Cancer Institute
Neurology & pain (4 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Cardiovascular (4 active studies)
- CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) · Corazon Medical PC
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart · Phase 3 · Boehringer Ingelheim
Diabetes & metabolic (1 active study)
Common conditions studied in Bay City
- Atopic Dermatitis (2 active studies)
- Chronic Pain (2 active studies)
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (2 active studies)
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (2 active studies)
- Coronary Artery Disease (2 active studies)
- Metastatic Malignant Neoplasm in the Brain (2 active studies)
Leading research sponsors in Bay City
- Eli Lilly and Company
- NRG Oncology
- Barbara Ann Karmanos Cancer Institute
- Alliance for Clinical Trials in Oncology
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Bay City?
There are approximately 30 recruiting clinical trials in Bay City, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bay City pay participants?
Most recruiting trials in Bay City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bay City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bay City?
The most common conditions under active study in Bay City include Atopic Dermatitis (2), Chronic Pain (2), Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (2), Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bay City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bay City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bay City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bay City?
Recruiting research sites in Bay City include McLaren Cancer Institute-Bay City, Great Lakes Research Group, Inc., Karmanos Cancer Institute at McLaren Bay Region, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bay City right now?
The largest active categories in Bay City are Cancer & tumors (13), Neurology & pain (4), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.